(Q37472494)

20 August 2017

NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients (English)

1 reference

20 August 2017

1 reference

Paul Lau

1

1 reference

20 August 2017

Joseph L Chin

2

1 reference

20 August 2017

Stephen Pautler

3

1 reference

20 August 2017

Hassan Razvi

4

1 reference

20 August 2017

Jonathan I Izawa

5

1 reference

20 August 2017

1 December 2009

1 reference

Canadian Urological Association journal

20 August 2017

1 reference

20 August 2017

3

1 reference

20 August 2017

454-458

1 reference

20 August 2017

6

1 reference

Biomarkers for detection and surveillance of bladder cancer.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Defining the role of NMP22 in bladder cancer surveillance

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Nuclear structure in cancer cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Experimental observations of a nuclear matrix

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Contemporary management of superficial bladder cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Preferential expression of NuMA in the nuclei of proliferating cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

NuMA is required for the proper completion of mitosis.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Nuclear matrix proteins reflect cell type of origin in cultured human cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Utility of serial urinary tumor markers to individualize intervals between cystoscopies in the monitoring of patients with bladder carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Bladder cancer: epidemiology, staging and grading, and diagnosis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2792415

Surveillance for recurrent bladder cancer using a point-of-care proteomic assay

2 September 2018

1 reference

12 December 2020

Detection of bladder cancer using a point-of-care proteomic assay

1 reference

12 December 2020

Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection

1 reference

12 December 2020

Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment

1 reference

12 December 2020

Identifiers

1 reference

20 August 2017

1 reference